SYDNEY, AUSTRALIA--(Marketwire - April 27, 2012) - Prima BioMed (Prima) (ASX: PRR) (NASDAQ: PBMD) today released its Appendix 4C - Quarterly Report for the three month period ending 31 March 2012.

The cash balance as of 31 March 2012 was A$ 42.8 million. The majority of funds spent during the quarter are related to development activities of Prima's lead product Cvac™.

Business highlights from the quarter:

• TGA grants Manufacturing License for CVac™ in Australia

• Commencement of ovarian cancer patient enrolment for CANVAS

• Registration Statement filed for NASDAQ listing

• Japanese patent granted for Cripto-1 antibody

For more details about these highlights, please refer to Prima's previous releases on the ASX website.

Appendix 4C - 3^rd Quarter

Quarterly Report

For Entities Admitted on the Basis of Commitments

Introduced 31/3/2000. Amended 30/9/2001

Name of Entity:
Prima BioMed Ltd (ASX: PRR)
ABN:		Quarter Ended ("Current Quarter")
90 009 237 889		31 March 2012

Consolidated Statement of Cash Flows

			Current Quarter		Year-to-Date
	Cash flows related to operating activities		$A'000		$A'000
1.1	Receipts from customers		13		13
1.2	Payments for
	(a) staff costs		(800)		(2,053)
	(b) advertising and marketing		(86)		(185)
	(c) research and development		(4,026)		(11,821)
	(d) leased assets		-		-
	(e) other working capital		(473)		(2,872)
1.3	Dividends received		-		-
1.4	Interest and other items of a similar nature received		625		1,726
1.5	Interest and other costs of finance paid		-		-
1.6	Income taxes benefit		-		764
1.7	Other - grants received		-		-
	Net operating cash flows		(4,747)		(14,428)

					Current Quarter $A'000		Year-to-Date $A'000
1.8		Net operating cash flows (carried forward)			(4,747)		(14,428)
Cash flows related to investing activities
1.9		Payment for acquisition of:
			(a) businesses (item 5)		-		-
			(b) equity investments		-		-
			(c) intellectual property		-		-
			(d) physical non-current assets		(218)		(538)
			(e) other non-current assets		-		-
1.10		Proceeds from disposal of:
			(a) businesses (item 5)		-		-
			(b) equity investments		-		-
			(c) intellectual property		-		-
			(d) physical non-current assets		-		-
			(e) other non-current assets		-		-
1.11		Loans to other entities			-		-
1.12		Loans repaid by other entities			-		-
1.13		Other (provide details if material)			-		-
Net investing cash flows					(218)		(538)
1.14		Total operating and investing cash flows			(4,965)		(14,966)
Cash flows related to financing activities
1.15		Proceeds from issues of shares, options, etc.			172		1,821
1.16		Transfer of shares			-		-
1.17		Proceeds from borrowings net finance costs			-		-
1.18		Repayment of borrowings			-		-
1.19		Dividends paid			-		-
1.20		Other - capital raising costs			-		-
Net financing cash flows					172		1,821
Net increase (decrease) in cash held					(4,793)		(13,145)
1.21		Cash at beginning of quarter/year to date			47,475		55,919
1.22		Exchange rate adjustments to item 1.21			142		50
1.23		Cash at end of quarter			42,824		42,824

Payments to Directors of the Entity and Associates of the Directors

Payments to Related Entities of the Entity and Associates of the Related Entities

		Current Quarter
		$A'000
1.24	Aggregate amount of payments to the parties included in item 1.2	277
1.25	Aggregate amount of loans to the parties included in item 1.11	-
1.26	Explanation necessary for an understanding of the transactions
	Directors' fees and consulting fees at normal commercial rates

Non-Cash Financing and Investing Activities

2.1	Details of financing and investing transactions which have had a material affect on consolidated Assets and liabilities but did not involve cash flows
2.2	Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Financing Facilities Available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

			Amount Available		Amount Used
			$A'000		$A'000
3.1	Loan facilities		-		-
3.2	Credit standby arrangements		12,000*		-

Note:
3.2 $12 million equity drawdown facility in place with Foretrend Securities Pty Ltd.

Reconciliation of Cash

Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows.			Current Quarter		Previous Quarter
			$A'000		$A'000
4.1	Cash on hand and at bank		2,963		601
4.2	Deposits at call		2,258		9,961
4.3	Bank overdraft		-		-
4.4	Other (Term Deposit)		37,303		36,913
	Total: Cash at end of quarter (item 1.23)		42,824		47,475

Acquisitions and Disposals of Business Entities

			Acquisitions		Disposals
			(Item 1.9(a))		(Item 1.10(a))
5.1	Name of entity		-		-
5.2	Place of incorporation or registration		-		-
5.3	Consideration for acquisition or disposal		-		-
5.4	Total net assets		-		-
5.5	Nature of business		-		-

Compliance Statement

1. This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.

2. This statement does give a true and fair view of the matters disclosed.

Sign Here:

Date: Friday 27^th April 2012

Company Secretary

Print Name: Ian Bangs

Notes

1. The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position.  An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.

2. The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.

• 6.2  - reconciliation of cash flows arising from operating activities to operating profit or loss
• 9.2  - itemised disclosure relating to acquisitions
• 9.4  - itemised disclosure relating to disposals
• 12.1(a)  - policy for classification of cash items
• 12.3  - disclosure of restrictions on use of cash
• 13.1  - comparative information

3. Accounting Standards.  ASX will accept, for example, the use of International Accounting Standards for foreign entities.  If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.